Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib-Reference-Cited by-同舟云学术

Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib

Published:2015-01-01 Issue:1 Volume:372 Page:30-39
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Robert Caroline¹,Karaszewska Boguslawa¹,Schachter Jacob¹,Rutkowski Piotr¹,Mackiewicz Andrzej¹,Stroiakovski Daniil¹,Lichinitser Michael¹,Dummer Reinhard¹,Grange Florent¹,Mortier Laurent¹,Chiarion-Sileni Vanna¹,Drucis Kamil¹,Krajsova Ivana¹,Hauschild Axel¹,Lorigan Paul¹,Wolter Pascal¹,Long Georgina V.¹,Flaherty Keith¹,Nathan Paul¹,Ribas Antoni¹,Martin Anne-Marie¹,Sun Peng¹,Crist Wendy¹,Legos Jeff¹,Rubin Stephen D.¹,Little Shonda M.¹,Schadendorf Dirk¹

Affiliation:

1. The authors' affiliations are listed in the Appendix.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1412690

Cited by 2117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Colitis in 2 Patients with Melanoma Treated with BRAF/MEK Inhibitors: Case Report and Literature Review;Case Reports in Oncology;2024-02-02

2. Immune subtyping of melanoma whole slide images using multiple instance learning;Medical Image Analysis;2024-02

3. Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma;International Journal of Molecular Sciences;2024-01-31

4. BRAF — a tumour-agnostic drug target with lineage-specific dependencies;Nature Reviews Clinical Oncology;2024-01-26

5. Case 2-2024: A 57-Year-Old Woman with Melanoma and Fever;New England Journal of Medicine;2024-01-18